Hellen Berger

Hellen Berger is a business writer based in Sao Paulo, Brazil.

Prior to price escalation of pharmaceutical products in Brazil, the country's regulatory authority released a study on price-cap control and its benefits in the past years.

Brazil's major vaccine producer innovates with stem-cell research.

The health ministry of Brazil recently signed an agreement to obtain its production technology to locally develop the antiretroviral drug atazavanir sulfate.

Brazil takes first steps towards gaining quality requirements for pharmaceutical excipients.

Brazil's generic-drug market is growing steadily.

Growth and change in Brazil and Mexico offer key opportunities for the region's pharmaceutical industry.

Brazil develops its first national plasma fractionation plant.

A look at why Brazil revised its GMP standards and how the changes will affect the local pharmaceutical industry.

The growth of Brazil's generic-drug market is on a fast track, but what are the projections for the sector's future?